Milestone Scientific (MLSS) vs Nephros (NEPH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Milestone Scientific (MLSS) has outperformed Nephros (NEPH) over the past year, losing 23.4% versus a loss of 36.2%. Over five years, NEPH leads with a -57.6% price change compared with -82.9% for MLSS. Nephros is the larger company by market cap ($35.7 million vs $32.6 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MLSS | NEPH |
|---|---|---|
| Share price | $0.36 | $3.29 |
| Market cap | $32.62M | $35.73M |
| 1-day change | -2.70% | +2.81% |
| YTD return | +33.33% | -32.58% |
| 1-year return | -23.40% | -36.24% |
| 5-year return | -82.94% | -57.60% |
| P/E ratio (TTM) | — | 21.93 |
| Forward P/E | — | 15.67 |
| EPS (TTM) | $-0.04 | $0.15 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $0.58 | $6.42 |
| 52-week low | $0.22 | $2.66 |
| Distance from 52-week high | -37.93% | -48.75% |
| Analyst consensus | none | none |
| Avg. price target upside | +247.22% | +89.97% |
| Average volume | 128.06K | 27.59K |
| Shares outstanding | 90.61M | 10.86M |
| Employees | 15 | 36 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Instruments & Supplies | Medical Instruments & Supplies |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MLSS has outperformed NEPH by 12.8 percentage points over the past year.
About Milestone Scientific
MLSS stock →Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments.
Healthcare · Medical Instruments & Supplies · 15 employees
About Nephros
NEPH stock →Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities.
Healthcare · Medical Instruments & Supplies · 36 employees
MLSS vs NEPH FAQ
Which is bigger, Milestone Scientific or Nephros?
Nephros (NEPH) is larger, with a market capitalization of $35.73M compared with $32.62M for Milestone Scientific (MLSS).
Which stock has performed better over the past year, MLSS or NEPH?
MLSS returned -23.40% over the past 12 months, compared with -36.24% for NEPH (price return, excluding dividends). Past performance does not predict future results.
Are Milestone Scientific and Nephros in the same industry?
Yes. Both are classified in the Medical Instruments & Supplies industry within the Healthcare sector.